AID is expressed in a subset of CML patients in lymphoid blast crisis, which promotes the genetic instability of tumor suppressors and DNA repair genes through point mutations and copy number alterations. This evidence concerns the gene AICDA and chronic myelogenous leukemia, BCR-ABL1 positive.